Mid-Day Market Update: Gold Surges 2%; Neuronetics Shares Plunge
Midway through trading Wednesday, the Dow traded down 0.43% to 34,229.72 while the NASDAQ rose 0.40% to 14,524.02. The S&P also fell, dropping 0.10% to 4,346.21.
39 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.
Mid-Morning Market Update: Markets Mixed; JPMorgan Posts Upbeat Earnings
Following the market opening Wednesday, the Dow traded down 0.36% to 34,254.62 while the NASDAQ rose 0.27% to 14,505.47. The S&P also fell, dropping 0.07% to 4,347.49.
The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
Here's a roundup of top developments in the biotech space over the last 24 hours.
20 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Puxin Limited (NYSE: NEW) rose 52.1% to $0.6901 in pre-market trading after dipping 24% on Tuesday.
BTIG Downgrades Neuronetics to Neutral
BTIG analyst Marie Thibault downgrades Neuronetics (NASDAQ:STIM) from Buy to Neutral.
Neuronetics Reports Commercial Deal With Success TMS
Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from neurohealth disorders,
Neuronetics’ NeuroStar Mental Health Therapy Shows Better Safety Over H-Coil TMS
Neuronetics Inc (NASDAQ:STIM) has announced that a peer-reviewed paper showed significantly lower seizure risk with NeuroStar Advanced Therapy for Mental Health…